Using Data to Develop Better Treatments for Leukemia

Currently, treatments for acute myeloid leukemia (AML) are limited to
a small number of chemotherapy drugs, and 5-year survival rates are only 25%. Now, UW Medicine researchers are using A.I. algorithms to develop more precise treatments for patients with acute myeloid leukemia (AML). Click below to learn more about this exciting research in a new video featuring ISCRM's own Dr. Pamela Becker and Dr. Su-In Lee from the UW School of Medicine.

Watch Video


More Events